These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2511618)

  • 1. Parkinson's disease update.
    Friedman JH
    R I Med J (1976); 1989 Nov; 72(11):393-8. PubMed ID: 2511618
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials of neuroprotection in Parkinson's disease: long-term selegiline and alpha-tocopherol treatment.
    LeWitt PA
    J Neural Transm Suppl; 1994; 43():171-81. PubMed ID: 7884399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease: new treatment strategies.
    Ahlskog JE
    Compr Ther; 1990 Dec; 16(12):41-6. PubMed ID: 2127559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selegiline: a second look. Six years later: too risky in Parkinson's disease.
    Prescrire Int; 2002 Aug; 11(60):108-11. PubMed ID: 12199263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroprotective and neurorestorative therapy in Parkinson's disease].
    Jiménez-Jiménez FJ; Molina JA
    Rev Neurol; 1997 Aug; 25 Suppl 2():S185-93. PubMed ID: 9280687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study design problems of DATATOP study analysis.
    Mäki-Ikola O; Heinonen E
    Ann Neurol; 1996 Dec; 40(6):946-8. PubMed ID: 9007106
    [No Abstract]   [Full Text] [Related]  

  • 7. Adrenal medulla autografts in Parkinson's disease: a proposed mechanism of action.
    Riopelle RJ
    Can J Neurol Sci; 1988 Nov; 15(4):366-70. PubMed ID: 3061629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adrenomedullary-brain transplant: a breakthrough in the management of Parkinson's disease].
    Bartal A
    Harefuah; 1988 Jun; 114(11):570-2. PubMed ID: 3396995
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug trial for Parkinson's.
    Lewin R
    Science; 1987 Jun; 236(4807):1420. PubMed ID: 3109033
    [No Abstract]   [Full Text] [Related]  

  • 10. Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2.
    Pham DQ; Plakogiannis R
    Ann Pharmacother; 2005 Dec; 39(12):2065-72. PubMed ID: 16288072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease. A cure using brain transplants?
    Snyder SH
    Nature; 1987 Apr 30-May 6; 326(6116):824-5. PubMed ID: 3574457
    [No Abstract]   [Full Text] [Related]  

  • 12. Adrenal-to-brain transplants continue as neurologists test two new drugs.
    Merz B
    JAMA; 1987 Aug; 258(7):881-2. PubMed ID: 3112422
    [No Abstract]   [Full Text] [Related]  

  • 13. Mortality in DATATOP: a multicenter trial in early Parkinson's disease. Parkinson Study Group.
    Ann Neurol; 1998 Mar; 43(3):318-25. PubMed ID: 9506548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
    Henchcliffe C; Schumacher HC; Burgut FT
    Expert Rev Neurother; 2005 Nov; 5(6):811-21. PubMed ID: 16274338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism.
    Shoulson I
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S160-6. PubMed ID: 9749589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent research advances in Parkinson's disease: Part II. Studies in lower animals indicate a future for brain implants.
    Friedman J
    R I Med J (1976); 1986 Aug; 69(8):361-3. PubMed ID: 3484342
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Evidence is insufficient to show that combined treatment increases mortality.
    Aaltonen H; Kilkku O; Heinonen E; Mäki-Ikola O
    BMJ; 1998 Dec; 317(7172):1586-7. PubMed ID: 9890764
    [No Abstract]   [Full Text] [Related]  

  • 18. Brain graft surgery: a new treatment for Parkinson's disease.
    Bradbury KM; Bauer M
    Crit Care Nurse; 1990 Sep; 10(8):15-31. PubMed ID: 2401155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R-(-)-deprenyl as a possible protective agent in Parkinson's disease.
    Tetrud JW; Langston JW
    J Neural Transm Suppl; 1987; 25():69-79. PubMed ID: 3123606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Parkinson's disease. From theory to practice.
    Ahlskog JE
    Postgrad Med; 1994 Apr; 95(5):52-4, 57-8, 61-4 passim. PubMed ID: 8153048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.